Infertility associated with pcos
1 / 22


  • Uploaded on

INFERTILITY ASSOCIATED WITH PCOS. Dr. Norlia Bahauddin Hospital Kajang. Mdm SH. A 28 year old Malay, nulliparous, married for 2 years. No medical illness. Initially regular menses Past 2 years, menses became oligomenorrhoeic, every 12-20 weeks apart, lasting 2-3 days .

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about ' INFERTILITY ASSOCIATED WITH PCOS' - lois

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Infertility associated with pcos


Dr. Norlia Bahauddin

Hospital Kajang

Mdm sh
Mdm SH

  • A 28 year old Malay, nulliparous, married for 2 years.

  • No medical illness.

  • Initially regular menses

  • Past 2 years, menses became oligomenorrhoeic, every 12-20 weeks apart, lasting 2-3 days 

  • Increase in weight  within 2 years

  • She is a non smoker and non drinker

  • The couple had regular unprotected intercourse

  • Husband healthy, no erectile dysfunction or premature ejaculation

  • Obese lady, BMI: 34kg/m². Acne present. No hirsutism seen or signs of insulin resistant such as acanthosisnigrican seen.

  • Ultrasound examination noted polycystic ovaries

  • Investigation result

    • FSH/LH: 5.7/9.1

    • Mid Luteal progesterone: 0.22ng/ml

    • T4/TSH: 2.67/17.2

    • Testosterone: 2.85nmol/L

    • MGTT: Fasting4.6mmol/L / 2H postprandial 8.5mmol/L

    • Pap smear: NILM

    • SFA: normal

  • Advised to reduce weight, referred to a dietician.

  • Commenced on ovulation induction.

  • Metformin  given in view of impaired glucose tolerance test.

  • She was started on clomiphene citrate for 3cycles (50mg od x1, 100mg od x2), however failed (no dominant follicle seen during follicular tracking).

  • Proceeded for laparoscopic dye test and ovarian drilling. Intraoperatively noted right polyscystic ovary. Both fallopian tubes patent.

  • Given another cycle of clomid 100mg od, which failed .

  • Then given 1 cycle of S/C Puregon(75iu x5/7,150iu x 7/7)

  • Follicular tracking showed a dominant follicle  right ovary (18mm).Triggered with  HCG (IM Pregnyl 10000iu) followed by IUI 36 hours later.

  • Unfortunately, subsequent Intraoperatively noted right polyscystic ovary. Both fallopian tubes patent.follow up  noted an ectopic pregnancy and a  diagnostic laparoscope showed a left tubal pregnancy and left salphyngectomy was done.

DISCUSSION Intraoperatively noted right polyscystic ovary. Both fallopian tubes patent.

  • Definition of PCOS, with two out of  three  criteria being diagnostic:

    • polycystic ovaries (12 or more peripheral follicles, 2-9mm ) or increased ovarian volume (greater than 10 cm3)

    • oligo- or anovulation

    • clinical and/or biochemical signs of hyperandrogenism

  • Anovulation is common among women with PCOS. hypertension, dyslipidemia, and an increased prothrombotic state.

  • Hyperandrogenism, in conjuction with hyperinsulinaemia are cardinal features of PCOS .

  • Follicular testosterone level have been shown to be elevated in PCOS.

  • High androgen levels may  contribute to  lower fertilization rates.

  • Glycodelin is a secretory protein from the endometrium and is a marker of endometrial receptivity.

  • High androgen levels in PCOS attribute to a reduction in glycodelin and therefore a reduction in endometrial receptivity.

  • Management of infertility in PCOS includes lifestyle modification and assisted reproductive technology such as ovulation induction.

  • For overweight women with PCOS who are anovulatory, diet adjustments and weight loss are associated with resumption of spontaneous ovulation in some women

  • Clomiphene citrate is the first-line treatment in  anovulatory patients with PCOS.

  • The cumulative pregnancy rate with clomiphene citrate after 6 months of treatment is between 40% and 50%.

  • Women who remain anovulatory can be stimulated with low dose gonadotropins.

  • Metformin as a first line agent in ovulation induction is less effective than clomiphene; lower ovulation and pregnancy rates

  • However, metformin benefits women with clomiphene resistance

  • Non obese PCOS women benefit the most from metformin; improves live birth rate

  • Metformin use is also associated with reduced OHSS

  • Surgery can be attempted in cases where ovaries are resistant to stimulation/ovulation induction. 

  • The polycystic ovaries can be treated with a laparoscopic procedure called "ovarian drilling" (A total of 3 to 10 punctures, 7 to 8 mm in depth are made in each ovary depending on its size. Each penetration lasts 4 to 5 seconds).

  • This results in  resistant to stimulation/ovulation induction. resumption of spontaneous ovulations or ovulations after adjuvant treatment with clomiphene or FSH.

  • Unlike ovarian stimulation treatment, drilling is not associated with an increased risk of multiple pregnancy.

  • LOD destroys ovarian androgen producing tissue and reduces peripheral conversion of androgens to estrogens.

  • A fall in the serum levels of androgens and LH and an increase in FSH levels occur.

  • This converts an adverse androgen dominant intrafollicular environment to an estrogenic one and restores the hormonal environment.  

  • This can restore ovulatory function

  • Anti mullerian hormone (AMH) is a biomarker that has been investigated as a risk factor for OHSS

  • Secreted by granulosa cells in pre-antral and small antral follicles

  • Used to estimate ovarian reserve and predict ovarian response to gonadotrophin stimulation

  • Higher AMH levels is associated with OHSS

Thank you

THANK YOU investigated as a risk factor for OHSS